SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism

Launched by AMERICAN FEDERATION OF MEDICAL SYNERGETICS · Jul 18, 2017

Keywords

ClinConnect Summary

This clinical trial, called the SQUED™ Series 28.1, is looking into a new way to understand and potentially treat autism spectrum disorder (ASD) in children. The main goal is to study how the brains of children with autism respond differently to certain brain patterns, known as "Autowave reverberators," compared to children without autism. Researchers believe that these differences in brain activity might contribute to the symptoms of autism. Participants will use a non-invasive device at home designed to help with this treatment.

To be eligible for the study, participants should have a clinical diagnosis of autism or related conditions and may have experienced certain types of brain or neck injuries at birth. The trial is open to individuals aged from just over one month to 21 years. Participants will engage in tasks appropriate for their age, and the study will involve monitoring specific brain activity patterns. It's important to note that individuals with certain medical conditions, such as blindness or deafness, or those with implanted devices like pacemakers, cannot participate. This trial aims to gather important insights that could lead to better treatments for autism.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of autism or related conditions.
• * History of Late complications at Natal Trauma:
• • 1. Cerebral level of Natal Trauma - brain injury;
• • 2. Cervical level of Natal Trauma - injury of vertebral;
• • 3. Cerebral anoxia.
• • Identified language deficit(s) and/or other cognitive or behavioral impairments (which will be specific to each sub-study).
• * Adequate ability to perform the research tasks set for the Age level:
• • 1. Infant - greater than 1 month to 2 years of age;
• • 2. Child - greater than 2 to 12 years of age;
• • 3. Adolescent - greater than 12 through 21 years of age.
• * Presence on the Skin of the interruption of Autowave front (interruption of hair separatrix - dorsal/ventral) and/or of the Autowave Reverberators:
• • 1. Photo of Spiral Autowaves, generated by the kernel of Autowave Reverberator - the kernel having an excitation "tongue";
• • 2. Graphics on tracing paper of Spiral Autowaves, generated by the kernel of Autowave Reverberator - the kernel having an excitation "tongue".
• * Presence of Clinical protocol CRF-SQUED™:
• • 1. Diagnostics of Autowave reverberators and Nonlinear Control of Autowave reverberators in Active media (Autowave interaction of patient - Algorithmic approach);
• • 2. Mathematical Modeling of Autowave Reverberator and Computational Simulation of the treatment code (Trade Secret), and creation Active medium SQUED™ for a patient;
• • 3. Recording for a patient of treatment code (Trade Secret) - Autowave regime: Hysteresis of Spiral Autowaves; Drift of Spiral Autowaves; Annihilation of Autowave reverberator.
• • Magnetogram of region of Home-use and Geographic coordinates of Home-use.
• Exclusion Criteria:
• • Peripheral blindness - precludes use of Image converter SQUED™ (iSQUED™).
• • Peripheral deafness - precludes use of Sound converter SQUED™ (sSQUED™).
• • Any implanted metal device - precludes use of Electromagnetic converter SQUED™ (eSQUED™).
• • Any implanted cardiac pacemaker - precludes use of Electromagnetic converter SQUED™ (eSQUED™).